TY - JOUR
T1 - α-Blocker Therapy of Hypertension
T2 - An Unfulfilled Promise
AU - Khoury, Alexander F.
AU - Kaplan, Norman M
PY - 1991/7/17
Y1 - 1991/7/17
N2 - For various reasons, the α1-receptor blocker prazosin has been used infrequently as initial therapy for hypertension. The introduction of additional agents of this class with properties different from prazosin provides slower onset of action, which should reduce the degree of first-dose and postural hypotension and a longer duration of action, which allows for once-a-day dosage. A summary of the published data on efficacy, side effects, and special properties of this class of agents indicates that they will probably be used more extensively, particularly because of their ability to improve lipid and glucose-insulin metabolism.
AB - For various reasons, the α1-receptor blocker prazosin has been used infrequently as initial therapy for hypertension. The introduction of additional agents of this class with properties different from prazosin provides slower onset of action, which should reduce the degree of first-dose and postural hypotension and a longer duration of action, which allows for once-a-day dosage. A summary of the published data on efficacy, side effects, and special properties of this class of agents indicates that they will probably be used more extensively, particularly because of their ability to improve lipid and glucose-insulin metabolism.
UR - http://www.scopus.com/inward/record.url?scp=0025868129&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025868129&partnerID=8YFLogxK
U2 - 10.1001/jama.1991.03470030094030
DO - 10.1001/jama.1991.03470030094030
M3 - Article
C2 - 1676077
AN - SCOPUS:0025868129
SN - 0098-7484
VL - 266
SP - 394
EP - 398
JO - JAMA: The Journal of the American Medical Association
JF - JAMA: The Journal of the American Medical Association
IS - 3
ER -